Optimizing Emergency Department Clinical Decision Support to Improve Buprenorphine Use in Opioid Use Disorder
A Study Comparing Original and Enhanced EMBED Systems
Led by Yale University · Updated on 2026-06-11
1912
Participants Needed
3
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
Researchers are evaluating the EMBED clinical decision support system to improve emergency department ED physicians adherence to standard care for administering buprenorphine to patients with opioid use disorder OUD. This study uses a Multiphase Optimization Strategy MOST framework, including preparation, optimization, and confirmatory phases, to refine and optimize EMBED for better usability and implementation. The goal is to enhance treatment initiation rates during emergency care for individuals with OUD.
The optimization phase has two stages Stage 1 involves a 2x2x2 factorial trial testing sustainable implementation strategies such as nurse prompts for withdrawal assessment, targeted clinician prompts to use the CDS, and patient-facing materials to promote equity and motivate readiness for treatment. Stage 2 focuses on improving CDS usability through serial randomized testing to minimize user errors, workflow disruption, and abandonment by refining the interface and workflow. In the evaluation phase, a randomized trial compares the effectiveness of the optimized package with the original EMBED system on rates of buprenorphine initiation in the ED.
Participants engage with the clinical decision support integrated into the electronic health record workflow, which assists in diagnosing OUD, assessing withdrawal severity, motivating patients through brief negotiation interviews, and automating documentation, order entry, prescribing, and referral for ongoing care. Researchers measure outcomes including the proportion of ED encounters with buprenorphine initiation and CDS engagement. The study spans multiple phases with continuous assessment to refine and confirm improvements in treatment initiation over time.
CONDITIONS
Brief Title
Adaptive Decision Support for Addiction Treatment Master
Research Team
E
Edward Melnick, MD, MHS
L
Laurel Buchanan
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
Factors
EMBED CDS interventions
Standard ED buprenorphine initiation
What it is
Adaptive versions of the EMBED clinician-facing clinical decision support system integrated into the emergency department electronic health record workflow, refined through optimization and evaluation stages
Initiation of buprenorphine in the emergency department with referral to outpatient treatment is current standard practice for opioid use disorder initiation
Role in trial
These are the actual intervention arms undergoing optimization and testing in the trial
Not part of the trial arms but used for external comparison of current practice
Primary use
To support clinicians in initiating buprenorphine in the ED through integrated decision support workflows
To initiate buprenorphine treatment during ED visit and facilitate outpatient follow-up
How it is used or performed
Clinician-facing prompts and workflows embedded in the electronic health record guide diagnosis, withdrawal assessment, motivational interview scripting, ordering, documentation, and referral
Clinician assesses withdrawal and offers buprenorphine and referral, without integrated CDS support
Evidence status
Effectiveness not yet established—trial is testing whether EMBED CDS improves buprenorphine initiation workflows
ED-initiated buprenorphine initiation has been associated with improved treatment engagement and reduced overdose mortality
Important limitations
Unknown whether CDS-driven workflow will improve initiation rates, and whether optimization phases translate to real-world adoption
Implementation in ED may be limited by clinician training, workflow interruption, and access to follow-up care
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
Who Can Participate
Age: 18Years +
All Genders
Eligibility Criteria
You may qualify if you...
Emergency department patient
18 years of age or older
Moderate to severe opioid use disorder
You will not qualify if you...
Under 18 years of age
Pregnant
Currently receiving medication for opioid use disorder
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Optimization Phase, Stage 1: Factorial Trial
Duration - Varies by participant
Participants experience different combinations of EMBED clinical decision support enhancements, including nurse prompts, clinician prompts, and patient materials to encourage treatment initiation.
Participants interact with the EMBED system as it undergoes iterative refinements to improve ease of use and reduce errors.
Evaluation Phase
Duration - Varies by participant
Participants receive either the optimized or original EMBED system to compare effectiveness in initiating buprenorphine treatment during emergency department visits.
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Similar Trials
Testing a Combined Treatment of Peer Support, Buprenorphine, and Telehealth to Reduce Opioid Overdoses After Emergency Department Discharge
Comparing Injectable and Sublingual Buprenorphine Treatments for Adults Using High Potency Synthetic Opioids with Opioid Use Disorder
Comparing Monthly Injectable vs Daily Oral Buprenorphine for Treating Opioid Use Disorder in Veterans
A Phase 4 Study of Two Buprenorphine Treatments Over One Year
Phase 2 Study of Brenipatide Added to Buprenorphine for Treating Opioid Use Disorder with or without Naloxone
Supportive Texting Chatbot for Pregnant and Postpartum Women with Opioid Use Disorder to Reduce Loneliness and Improve Care Engagement
Optimizing Emergency Department Clinical Decision Support to Improve Buprenorphine Use in Opioid Use Disorder
A Study Comparing Original and Enhanced EMBED Systems
Adaptive Treatment Strategies to Increase Long-Term Buprenorphine Use for Adults with Opioid Use Disorder in the Emergency Department
Using Peer Recovery Coach Training and AI Texting to Reduce Racial Disparities in Opioid Overdose Deaths
A Study to Improve Access to Opioid Treatment and Social Services in Black and Latinx Adults
Phase 1 Study of Psilocybin Safety and Effects in Adults with Opioid Use Disorder on BuprenorphineNaloxone
Study of Opioid Use Disorder Risk After Surgery in Adolescents Aged 12 to 17 Using Opioid Pain Medicine
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Adaptive decision support for addiction treatment to implement initiation of buprenorphine for opioid use disorder in the emergency department: protocol for the ADAPT Multiphase Optimization Strategy trial.
Mark S Iscoe, Carolina Diniz Hooper, Deborah R Levy...